Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
Depelsenaire ACI, Witham K, Veitch M, Wells JW, Anderson CD, Lickliter JD, Rockman S, Bodle J, Treasure P, Hickling J, Fernando GJP, Forster AH. Depelsenaire ACI, et al. Among authors: bodle j. PLoS One. 2021 Jul 30;16(7):e0255282. doi: 10.1371/journal.pone.0255282. eCollection 2021. PLoS One. 2021. PMID: 34329337 Free PMC article. Clinical Trial.
Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.
Maraskovsky E, Rockman S, Dyson A, Koernig S, Becher D, Morelli AB, Barnden M, Camuglia S, Bodle J, Vandenberg K, Wang IM, Cristescu R, Loboda A, Citron M, Fontenot J, Hung D, Schoofs P, Pearse M. Maraskovsky E, et al. Among authors: bodle j. Vaccine. 2012 Dec 7;30(51):7400-6. doi: 10.1016/j.vaccine.2012.09.083. Epub 2012 Oct 9. Vaccine. 2012. PMID: 23063831
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
Fernando GJP, Hickling J, Jayashi Flores CM, Griffin P, Anderson CD, Skinner SR, Davies C, Witham K, Pryor M, Bodle J, Rockman S, Frazer IH, Forster AH. Fernando GJP, et al. Among authors: bodle j. Vaccine. 2018 Jun 18;36(26):3779-3788. doi: 10.1016/j.vaccine.2018.05.053. Epub 2018 May 17. Vaccine. 2018. PMID: 29779922 Free article. Clinical Trial.
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
Forster AH, Witham K, Depelsenaire ACI, Veitch M, Wells JW, Wheatley A, Pryor M, Lickliter JD, Francis B, Rockman S, Bodle J, Treasure P, Hickling J, Fernando GJP. Forster AH, et al. Among authors: bodle j. PLoS Med. 2020 Mar 17;17(3):e1003024. doi: 10.1371/journal.pmed.1003024. eCollection 2020 Mar. PLoS Med. 2020. PMID: 32181756 Free PMC article. Clinical Trial.
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Ekimov A, Arunachalam AB, Blake T, Bodle J, Couzens L, Dubey S, Eichelberger M, Engelhardt OG, Gubinelli F, Joshi M, Melnyk D, Palladino G, Rigsby P, Rockman S, Savina N, Smith E, Gilchrist SAN; World Health Organization's Pandemic Influenza preparedness, Vaccine Response's Alternative Potency, Reagents Technical Working Group. Ekimov A, et al. Among authors: bodle j. Vaccine. 2023 Jul 19;41(32):4639-4647. doi: 10.1016/j.vaccine.2023.06.051. Epub 2023 Jun 19. Vaccine. 2023. PMID: 37344260 Free article.
44 results